Circ_0049472 downregulation relieves Amyloid-β-induced neuronal injury by modulating PDE4A expression via targeting miR-22-3p in Alzheimer's disease.

IF 3.5 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Jiao Chen, Sai Xiao, Xiaojie Cui, Xiao Gao, Danyang Wang, Xiaoming Li, Wenbo Qi, Bailing Wang
{"title":"Circ_0049472 downregulation relieves Amyloid-β-induced neuronal injury by modulating PDE4A expression via targeting miR-22-3p in Alzheimer's disease.","authors":"Jiao Chen, Sai Xiao, Xiaojie Cui, Xiao Gao, Danyang Wang, Xiaoming Li, Wenbo Qi, Bailing Wang","doi":"10.1007/s11011-025-01652-4","DOIUrl":null,"url":null,"abstract":"<p><p>Neuronal injury is a common event in the development of Alzheimer's disease (AD). Previous studies have suggested that circular RNAs (circRNAs) are involved in neuronal injury in the pathological progression of AD. However, the potential role of circ_0049472 in the AD process is still unclear. Amyloid-β (Aβ)-treated SK-N-SH and CHP212 cells were used as the cell model of AD in vitro. The expression of circ_0049472, miR-22-3p, and phosphodiesterase 4A (PDE4A) was measured by quantitative real-time PCR (qPCR). Cell viability, proliferation, and apoptosis were estimated by Cell Counting Kit-8 (CCK-8) assay, 5-ethynyl-2'-deoxyuridine (EdU) assay, and flow cytometry assay. Proliferating cell nuclear antigen (PCNA), B-cell lymphoma-2 (bcl-2), Bcl-2 related X protein (bax), cleaved-caspase 3, PDE4A, and Postsynaptic protein-95 (PSD-95) were determined using western blot. Interleukin-1β (IL-1β), IL-6, and tumor necrosis factor α (TNF-α) levels were analyzed using enzyme-linked immunosorbent assay (ELISA). JC-1 assay was utilized to evaluate mitochondrial function. Binding between miR-22-3p and circPLAR1 or PDE4A was predicted and verified using dual-luciferase reporter assay or RNA Immunoprecipitation (RIP) assay. Circ_0049472 and PDE4A were overexpressed in Aβ-treated SK-N-SH and CHP212 cells, and miR-22-3p was reduced. Knockdown of circ_0049472 might abolish Aβ-mediated proliferation inhibition and the promotion of apoptosis and inflammation, mitochondrial dysfunction in SK-N-SH and CHP212 cells. Mechanistically, circ_0049472 is competitively bound to miR-22-3p to elevate its target PDE4A. Circ_0049472 knockdown alleviated Aβ-induced SK-N-SH and CHP212 cell dysfunctions via targeting the miR-22-3p/PDE4A axis, suggesting that circ_0049472 knockdown might protect from neuronal injury in AD.</p>","PeriodicalId":18685,"journal":{"name":"Metabolic brain disease","volume":"40 7","pages":"252"},"PeriodicalIF":3.5000,"publicationDate":"2025-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Metabolic brain disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11011-025-01652-4","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Neuronal injury is a common event in the development of Alzheimer's disease (AD). Previous studies have suggested that circular RNAs (circRNAs) are involved in neuronal injury in the pathological progression of AD. However, the potential role of circ_0049472 in the AD process is still unclear. Amyloid-β (Aβ)-treated SK-N-SH and CHP212 cells were used as the cell model of AD in vitro. The expression of circ_0049472, miR-22-3p, and phosphodiesterase 4A (PDE4A) was measured by quantitative real-time PCR (qPCR). Cell viability, proliferation, and apoptosis were estimated by Cell Counting Kit-8 (CCK-8) assay, 5-ethynyl-2'-deoxyuridine (EdU) assay, and flow cytometry assay. Proliferating cell nuclear antigen (PCNA), B-cell lymphoma-2 (bcl-2), Bcl-2 related X protein (bax), cleaved-caspase 3, PDE4A, and Postsynaptic protein-95 (PSD-95) were determined using western blot. Interleukin-1β (IL-1β), IL-6, and tumor necrosis factor α (TNF-α) levels were analyzed using enzyme-linked immunosorbent assay (ELISA). JC-1 assay was utilized to evaluate mitochondrial function. Binding between miR-22-3p and circPLAR1 or PDE4A was predicted and verified using dual-luciferase reporter assay or RNA Immunoprecipitation (RIP) assay. Circ_0049472 and PDE4A were overexpressed in Aβ-treated SK-N-SH and CHP212 cells, and miR-22-3p was reduced. Knockdown of circ_0049472 might abolish Aβ-mediated proliferation inhibition and the promotion of apoptosis and inflammation, mitochondrial dysfunction in SK-N-SH and CHP212 cells. Mechanistically, circ_0049472 is competitively bound to miR-22-3p to elevate its target PDE4A. Circ_0049472 knockdown alleviated Aβ-induced SK-N-SH and CHP212 cell dysfunctions via targeting the miR-22-3p/PDE4A axis, suggesting that circ_0049472 knockdown might protect from neuronal injury in AD.

Circ_0049472下调通过靶向miR-22-3p调节PDE4A在阿尔茨海默病中的表达,减轻淀粉样蛋白β诱导的神经元损伤。
神经元损伤是阿尔茨海默病(AD)发展过程中的常见事件。先前的研究表明,环状rna (circRNAs)参与了阿尔茨海默病病理进展中的神经元损伤。然而,circ_0049472在AD过程中的潜在作用尚不清楚。以淀粉样蛋白-β (Aβ)处理的SK-N-SH和CHP212细胞作为AD的体外细胞模型。通过实时荧光定量PCR (qPCR)检测circ_0049472、miR-22-3p和磷酸二酯酶4A (PDE4A)的表达。通过细胞计数试剂盒-8 (CCK-8)测定、5-乙基-2′-脱氧尿苷(EdU)测定和流式细胞术测定细胞活力、增殖和凋亡。western blot检测增殖细胞核抗原(PCNA)、b细胞淋巴瘤-2 (bcl-2)、bcl-2相关X蛋白(bax)、裂解caspase 3、PDE4A、突触后蛋白-95 (PSD-95)。采用酶联免疫吸附试验(ELISA)分析白细胞介素-1β (IL-1β)、IL-6和肿瘤坏死因子α (TNF-α)水平。JC-1法评价线粒体功能。miR-22-3p与circPLAR1或PDE4A的结合是通过双荧光素酶报告基因法或RNA免疫沉淀(RIP)法预测和验证的。Circ_0049472和PDE4A在a β处理的SK-N-SH和CHP212细胞中过表达,miR-22-3p降低。敲低circ_0049472可能会消除a β介导的增殖抑制,促进SK-N-SH和CHP212细胞的凋亡和炎症,线粒体功能障碍。机制上,circ_0049472与miR-22-3p竞争性结合以提升其靶标PDE4A。Circ_0049472敲低可通过靶向miR-22-3p/PDE4A轴减轻a β诱导的SK-N-SH和CHP212细胞功能障碍,提示Circ_0049472敲低可能保护AD的神经元损伤。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Metabolic brain disease
Metabolic brain disease 医学-内分泌学与代谢
CiteScore
5.90
自引率
5.60%
发文量
248
审稿时长
6-12 weeks
期刊介绍: Metabolic Brain Disease serves as a forum for the publication of outstanding basic and clinical papers on all metabolic brain disease, including both human and animal studies. The journal publishes papers on the fundamental pathogenesis of these disorders and on related experimental and clinical techniques and methodologies. Metabolic Brain Disease is directed to physicians, neuroscientists, internists, psychiatrists, neurologists, pathologists, and others involved in the research and treatment of a broad range of metabolic brain disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信